VOLUME 73 AUTHOR INDEX - heart.bmj.com · BrHear _ 1995;73:587-588 VOLUME 73 * AUTHORINDEX Key:...
Transcript of VOLUME 73 AUTHOR INDEX - heart.bmj.com · BrHear _ 1995;73:587-588 VOLUME 73 * AUTHORINDEX Key:...
Br Hear_ 1995;73:587-588
VOLUME 73 * AUTHOR INDEX
Key: E = Editorial; F = Filler; L = Letter; C = Correction
Abrams S, 190Abrams SE, 177Accurso V, 258Adams JN, 87, 125, 265Adelman AG, 534Aggarwal RK, 392 (L), 571Agostini D, 69Ajayi AAL, 488 (L)Alday LE, 199 (L)Alkhulaifi AM, 304Amadi AA, 540Anderson RH, 559, 566Andrews R, 237Armstrong PW, 242Ashour S, 284Ayman M, 284
Baccillieri S, 258Ball J, 571Barker DJP, 116, 363Bamett DB, 540Bath PMW, 10Baur LHB, 227Beastall G, 41Beevers G, 584 (L)Beghetti M, 65Bellamy CM, 25Bent SE, 417Berner M, 65Berning J, 320, 506Berry C, 116Bhandari S, 110Billingham C, 173Block M, 158Bloomfield P, 391 (F)Bocker D, 158Bonarjee VVS, 506, 511Boon NA, 583 (L)Borggrefe M, 158Borland W, 41Boyle RM, 302 (E), 359, 413Brack M, 393 (L)Brawn WJ, 456, 479Breithardt G, 158Bridson JM, 99Brodie BR, 411Brooks M, 265Brouwer J, 134, 263Brown AH, 92Brunotte F, 61Bruschke AVG, 227Bu'Lock FA, 334, 340, 456Bull C, 164
Caforio ALP, 417Caidahl K, 506, 511Caillot D, 61Camesasca C, 355Camm AJ, 10Campbell NPS, 200 (L)Campbell RWF, 32Canavan C, 129Carstensen S, 506Carter R, 41Cary N, 73Castrucci M, 158Cats VM, 227Channer KS, 200 (L), 488 (L)Charles RG, 392 (L), 571Chen L, 216Chester M, 216Chester MR, 540Cheung B, 584 (L)Chierchia SL, 355Chiu RC-J, 1 (E)Choi JY, 544Choo KE, 523Choy A-MJ, 102 (L)Christie J, 466Clark AL, 445Clarkson MJ, 177Clausell N, 534, 581Coats AJ, 393 (L)Coats AJS, 395Cobbe SM, 41, 139, 466Coker SJ, 177Comerford DM, 576Connelly DT, 571Cooper JP, 169, 351Cottin Y, 61Coudert B, 61Cowan JC, 310, 397Cowell R, 103 (L)Cowley AJ, 237, 470Grsjns HIGM, 37, 103 (L), 134,
263
Cross DB, 500Cross SJ, 102 (L)Currie P, 351
Daly K, 422Daly LE, 576Daly PA, 581Darbar D, 102 (L)Dargie HJ, 466Davidson NC, 102 (L)Davies DW, 250Davies MK, 434Davis KB, 548Davis LM, 377Davis TME, 523Dawson F, 475Day INM, 368de Feyter PJ, 82De Giovanni JV, 401, 456, 479De Giovanni, 173de Groot A, 227De Jaegere PP, 407de Jaegere PP, 82de Lima VC, 534Dean J, 265Dickson D, 293Dickstein K, 511Dietz R, 517Dodds PA, 25Doherty JG, 475Doran J, 434Douglas PS, 548Dovigo P, 258Dunn FG, 527
Edner M, 506Eichhom Ch, 517Ellenbogen KA, 583 (L)Elliott MJ, 164Engvall J, 270Erbel R, 462
Fall CHD, 363Farooqi IS, 584 (L)Fastenrath C, 158Fischer JL, 293Forde A, 422Fragasso G, 355Francis CM, 390 (F)Freeman MR, 242French JK, 500Friedli B, 65Frolich M, 227Furniss SS, 32
Gaffney B, 129, 385Galatius-Jensen S, 488 (L)Galli M, 486Gandhi MM, 193Gang Y, 417Gannon F, 422Garratt CJ, 250Gatzoulis MA, 182, 445, 586 (L)Ge J, 462Gershlick AH, 393 (L)Giannico S, 355Gibbs JL, 99Gibson DG, 53, 151, 559Gilles A, 61Glennon PE, 496Goodfield NER, 110, 391 (F)Gorge G, 462Gotlieb Al, 534Graham IM, 576Gray CE, 41Gray D, 470Gray J, 265Grech ED, 414Greenwald S, 116Griffith MJ, 8, 92Grines CL, 405Guly UM, 372Gunn I, 102 (L)Gustavsson CG, 223
Haaksma J, 134Haberer T, 293Habre W, 65Hag OEL, 583 (L)Hall RJC, 302 (E)Hamer HPM, 37Hammel D, 158Hammill SC, 6Hampton JR, 470Hanlein D, 517
Hardy P, 115 (F)
Hargreaves AD, 583 (L)Hargreaves MR, 101 (L)Hart HH, 500Harvey K, 41Harwood R, 584 (L)Hassanin MM, 284Haude M, 462Hauer RNW, 442Heald SC, 250Heaviside DW, 92Henein MY, 151Henney AM, 209Henselmann L, 293Hess J, 49Hickey N, 576Higgins I, 576Higham PD, 32Ho SY, 182, 559, 566Holt PM, 76Houston AB, 383Hubner PJB, 393 (L)Humphries SE, 209, 368
Ibrahim J, 523lida H, 69Isbruch F, 158
Jagtap R, 456Jakob G, 145James MA, 392 (L)Jamieson M, 87Jamieson MPG, 277Jayawickreme SR, 169Jennings K, 102 (L)Jennings KP, 87, 125Jespersen S, 116Jin XY, 53John ASt, 523Johnston IDA, 237Jolobe OMP, 101 (L)Junker A, 320
Kane M, 422Kappenberger L, 107 (E)Karani S, 327Karlsson E, 270Kasem-Suwan P, 187Kaski JC, 216Katz A, 14Kaul S, 490Keating NA, 470Kee F, 129, 385Keeling PJ, 417Keirse MJNC, 227Kennedy NSJ, 102 (L)Kerr F, 475Khaira H, 199 (L)Kilcoyne D, 576Kim HS, 544Kinnear WJ, 237Klein GJ, 583 (L)Klein H, 20Kligfield P, 403Kofflard MJ, 82Koster JF, 208 (F)
Labovitz A, 548Lampe FC, 193Lang CC, 102 (L)Langer A, 242Latif S, 139Lavin F, 422Layton C, 199 (L)Leatham EW, 10Lee HS, 102 (L), 359Legault SE, 242Leslie RDG, 450Levy R, 14Lie KI, 37, 103 (L), 134, 263Lindsay HSJ, 397Lip GYH, 527, 584 (L), 586 (L)Little J, 129Littler WA, 122, 428Liu P, 534Lo SSS, 450Logan RW, 277Lorimer AR, 139Lote CJ, 434Louis P, 61Lowe GDO, 527Luft F, 517
Macauley D, 199 (L)Macfarlane PW, 139MairlJ, 145
Mandalia S, 209
Mandawat MK, 139Maraglino G, 258Martin RP, 334, 340Martin W, 466Martyn CN, 116Massing JL, 61Matthews D, 102 (L)McClements B, 200 (L)McConnell W, 129McEwan J, 489McKenna WJ, 417McLoughlin M, 576McNeill GP, 102 (L)Metcalfe MJ, 466Meyer J, 462Mickel MC, 548Mickley H, 320Mitchell IM, 277Mitha AS, 555Moller M, 320Molossi S, 534Morillo CA, 583 (L)Morley-Davies A, 110, 391 (F)Morris JL, 115 (F), 310Mott MG, 334, 340Mounsey JP, 92Muirhead RA, 25Mukhtar HT, 122Mulcahy D, 101 (L)Munclinger MJ, 555Murday V, 417
Nielsen JR, 320Nilsen DWT, 506, 511Noh CI, 544Norell MS, 390 (F)Norris RM, 500Nylander E, 270
Oakhill A, 340O'Brien I, 102 (L)O'Callaghan PA, 576O'Dell SD, 368Ohlin A-K, 223Ohlin H, 223Oldroyd KG, 41, 466Oliver MF, 299 (E)Oliver RM, 351Omboni S, 290Omland T, 506, 511O'Neill WW, 405Ormerod 0, 101 (L)Osmond C, 116, 363Osterziel KJ, 517O'Toole L, 200 (L)Otto CM, 548
Palatini P, 258Palmer RG, 392 (L)Pantev E, 223Papa M, 355Patel JJ, 555Patel N, 555Peart I, 190Perry RA, 25Pfitzner P, 20Pichler M, 145Plant WD, 110Politi A, 486Pollock JCS, 277Poole-Wilson PA, 496Porter J, 73Posma J. 37Potjalongsilp S, 187Prakash A, 76Pringle SD, 139Pringle TH, 102 (L)Pugsley WB, 304Puschendorf B, 145Pye M, 466
Quinn T, 359
Rabinovitch M, 534Ramsdale DR, 115 (F), 392 (L),
414Rao PS, 585 (L)Rashwan MA, 284Rawles JM, 87, 125Ray SG, 466, 571Redel DA, 383Redington AN, 182, 383, 445, 586(L)Redpath TW, 265Reid CL, 548
Reid DS, 92
587
Author Index
Richards DA, 377Riedinger-Berriolo A, 61Riesenberg K, 14Rigby ML, 182, 383, 586 (L)Riyami AAS, 139Robertson CE, 372Robinson K, 576Rose EL, 125Ross DL, 377Rowland E, 250Rumley A, 527Ruygrok P, 82
Sadiq M, 173Santoro F, 355Scheld HH, 158Schilling RJ, 390 (F)Schipperheyn nI, 227Schlaeffer F, 14Schnittger I, 306Schofield P, 73Seo H, 417Serruys PW, 82Sethia B, 456, 479Shaw TRD, 390 (F)Shearman C, 199 (L)Sheridan DJ, 428Shinebourne EA, 182Shore DF, 182Sideris EB, 585 (L)Sigwart U, 393 (L)Silove ED, 173, 456, 479Silver MD, 581Simmers TA, 442Simoons ML, 407Singh B, 523
Singh SP, 586 (L)Sluiter W, 208 (F)Smit AAJ, 290Smith FW, 265Smith G, 417Smyllie JH, 310Solimene MC, 101 (L)Song JY, 544Sonnhag C, 270Souverijn JHM, 227Sowton E, 327Spencer JL, 523Stanton MS, 6Starling R, 237Stenport G, 270Sticca M, 486Struthers AD, 102 (L)Stuart AG, 483Stumper 0, 173, 456, 479Sturaro M, 258Sugden PH, 496Sulke N, 327Sullivan ID, 164Sundsfiord JA, 511Sutherland GR, 110Sutton MStJ, 450Swanton RH, 169, 351Szab6 BM, 263
Takahashi A, 69Tan KH, 327Taub N, 327Telford AM, 129Thorvinger B, 223Tieleman RG, 37Timmers T, 49
Timmis AD, 103 (L)Tisi P, 199 (L)Tobe TJM, 108Tometzki AJP, 383Toniolo G, 258Tooze JA, 10Toubeau M, 61Touzery C, 61Townend JN, 434Trappe H-J, 20Trent RJ, 87, 125, 265Tulloh RMR, 164Turley E, 534
Uther JB, 377
Vaitkus PT, 409van Boven AJ, 134van den Berg MP, 263van den Brand M, 82van den Heuvel F, 49van der Laarse A, 227van Domburg R, 82Vijayakumar M, 363Vogel M, 566Voogd PJ, 227Vroom TFFP, 227
Walker JM, 351Walker P, 61Walker SK, 392 (L)Wallbridge DR, 139, 488 (L)Walsh JT, 237, 470Walsh KP, 177Walsh MJ, 576Walton S, 265Wang K, 559
Ward DE, 250Watson JD, 129Watts GF, 209Welch JC, 99Wenzlaff P, 20Westaby S, 203 (E)Wever EFD, 442White HD, 500Wieling W, 290Wiesfeld ACP, 37Willenbrock R, 517Williams BF, 500Wilmshurst P, 236 (F)Wilson AT, 488 (L)Wilson DG, 483Wilson N, 383Wisheart JD, 483Wittkampf FHM, 442WolfJE, 61Wood DA, 4 (E), 193Wranne B, 270Wright BY, 392 (L)Wright JGC, 173, 456, 479Wright JS, 103 (L)
Xiao HB, 53
Ye S, 209Yoshimura M, 585 (L)Youhana AY, 206 (F)Yun YS, 544
Zaman AG, 310, 397Zeina A-AA, 284Zijlstra F, 403Zoia E, 355
588
Br Heart J 1995;73:589-594
VOLUME 73 - SUBJECT INDEX
Ablation, Simultaneous mapping of the tricuspid and mitral valveannuli at electrophysiological study 377
Acadesine, Role of acadesine in clinical myocardial protection 304Access, Expanding access to coronary artery bypass surgery 129Accessory pathway, Simultaneous mapping of the tricuspid and
mitral valve annuli at electrophysiological study 377ACE gene polymorphisms, Rapid methods for population-scale
analysis for gene polymorphisms 368ACE inhibitorsACE for whom? Implications for clinical practice of post-infarct
trials 470ACE inhibitors after myocardial infarction 395, 397Combining salicylate and enalapril in patients with coronary
artery disease and heart failure 227Do radionuclide and echocardiographic techniques give a universal
cut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466
Responses of plasma concentrations of A type natriuretic peptideand B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heartfailure 584
Active compression-decompression device, Active decompres-sion improves the haemodynamic state during cardiopulmonaryresuscitation 372
Acute inferior myocardial infarction, Is thrombolytic therapy inacute inferior myocardial infarction really better than conven-
tional treatment? 108Acute myocardial infarction
Delay between the onset of symptoms of acute myocardial infarc-tion and seeking medical assistance is influenced by left ventric-ular function at presentation 125
Experience of primary angioplasty in the UK 414Immediate angioplasty 407Immediate angioplasty in the United Kingdom 413Left ventricular volumes, ejection fraction, and plasma proatrial
natriuretic factor (1-98) after withdrawal of enalapril treatmentinitiated early after myocardial infarction 506
Limitations of primary angioplasty in acute myocardial infarction409
Primary angioplasty 405Primary angioplasty in a community hospital in the USA 411Primary angioplasty in acute myocardial infarction 403Primary angioplasty is the most effective treatment for an acutemyocardial infarction 403
Prognostic significance of transient myocardial ischaemia afterfirst acute myocardial infarction 320
Survival after acute myocardial infarction in Asian and whitepatients in Birmingham 122
Adenosine, Haemodynamic deterioration after treatment withadenosine 103
adrenoceptor downregulation, adrenoceptor density in thedonor heart 540
Adult arterial compliance, Growth in utero, adult blood pressure,and arterial compliance 116
Adverse coronary events, Identification of patients at high risk foradverse coronary events while awaiting routine coronary angio-plasty 216
Advisers, List of advisers 394Agism
Issues in cardiac pacing 101Women and myocardial infarction 87
Alacepril, Responses of plasma concentrations ofA type natriureticpeptide and B type natriuretic peptide to alacepril, an
angiotensin-converting enzyme inhibitor, in patients with con-
gestive heart failure 584Alcohol, New year toast...to the cardioprotective effects of alcohol 8Angina
Incidence, clinical characteristics, and short-term prognosis ofangina pectoris 193
Vasoconstrictor peptides and cold intolerance in patients withstable angina pectoris 25
Angiography, Are the economically active more deserving? 385Angioplasty
Efficacy of a third coronary angioplasty for a second restenosis 327Guide wire graffito 505
Anomalous pulmonary venous connection, Fetal echocardiogra-
phy in detecting anomalous pulmonary venous connection 355Anthracycline
Impairment of diastolic function during short-term anthracyclinechemotherapy 61
Left ventricular diastolic function after anthracycline chemother-apy in childhood 340
Anticoagulation, Anticoagulation after intracoronary stent inser-tion 393
Systemic thromboembolism leading to myocardial infarction andstroke after fenestrated total cavopulmonary connection 483
Antioxidants, Antioxidant nutrients, atherosclerosis, and coronaryheart disease 299
Antiviral therapy, Potential for antiviral therapy in the treatmentof restenosis after angioplasty 489
Aortic coarctationArm-ankle systolic blood pressure difference at rest and after exer-
cise in the assessment of aortic coarctation 270Mitral valve hypoplasia in children with isolated coarctation of the
aorta 199Aortic elastic properties, Aortic distensibility and stiffness index
measured by magnetic resonance imaging in patients withMarfan's syndrome 265
Aortic stenosisComparison of Doppler echocardiographic methods with heart
catheterisation in assessing aortic valve area in 100 patients withaortic stenosis 293
Gender differences in left ventricle geometry and function inpatients undergoing balloon dilatation of the aortic valve forisolated aortic stenosis 548
Nitrates and severe aortic stenosis 586Aortic valve area, Comparison of Doppler echocardiographic
methods with heart catheterisation in assessing aortic valve areain 100 patients with aortic stenosis 293
Arterial duct, Responses of the post-term arterial duct to oxygen,prostaglandin E2, and the nitric oxide donor, 3-morpholinosyd-nonimine, in lambs and their clinical implications 177
Asians, Insulin resistance, high prevalence of diabetes, and cardio-vascular risk in immigrant Asians 584
Asymptomatic ischaemia, Asymptomatic ischaemia during dailylife in stable coronary artery disease 101
AtherosclerosisAntioxidant nutrients, atherosclerosis, and coronary heart disease299
High wall shear stress proximal to myocardial bridging and athero-sclerosis 462
Is increased tissue ferritin a risk factor for atherosclerosis andischaemic heart disease? 208
Atrial anatomy, Architecture of atrial musculature in humans 559Atrial fibrillation
Increased markers of thrombogenesis in chronic atrial fibrillation527
Value of transoesophageal echocardiography before DC cardio-version in patients with atrial fibrillation 306
Atrial flutter, Effect of exercise on cycle length in atrial flutter 263Atrial muscles, Architecture of atrial musculature in humans 559Atrioventricular conduction, Change in delay of atrioventricular
conduction after radiofrequency catheter ablation for atrioven-tricular nodal re-entry tachycardia 442
Atrioventricular node, Change in delay of atrioventricular con-duction after radiofrequency catheter ablation for atrioventricu-lar nodal re-entry tachycardia 442
Audit ofpacemaker practice, Permanent pacemaker practice at aScottish district general hospital between 1987 and 1993 475
Autonomic failure, Twenty four hour continuous non-invasivefinger blood pressure monitoring 290
Autonomic nervous system, Differential autonomic mechanismsunderlying early morning and daytime transient myocardialischaemia in patients with stable coronary artery disease 134
Birth weight, Birth weight, weight at one year, and left ventricularmass in adult life 363
Bjork-Shiley mitral valve prosthesis, Strut fracture of theConvexo-Concave Bjork-Shiley mitral valve prosthesis 391
Blalock-Taussig shunts, Closure of Blalock-Taussig shunts using anew detachable coil device 383
589
Subject Index
Blood pressureArm-ankle systolic blood pressure difference at rest and after exer-
cise in the assessment of aortic coarctation 270Growth in utero, adult blood pressure, and arterial compliance116
Body surface area, Left ventricular diastolic function in childrenmeasured by Doppler echocardiography 334
British Cardiac Society, Report of a working group of the BritishCardiac Society 201
CaptoprilEffects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237
Peripheral haemodynamic effects of inhibition of prostaglandinsynthesis in congestive heart failure and interactions with capto-pril 434
Cardiac catheterisation, Comparison of Doppler echocardio-graphic methods with heart catheterisation in assessing aorticvalve area in 100 patients with aortic stenosis 293
Cardiac defects, Transcatheter occlusion of cardiac defects 585Cardiac failure, 0) adrenoceptor density in the donor heart 540Cardiac function, Plasma proatrial natriuretic factor (1-98) con-
centration after myocardial infarction 511Cardiac hypertrophy, Cellular mechanisms of cardiac hypertro-
phy 496Cardiac marker proteins, Comparison of five cardiac markers in
the detection of reperfusion after thrombolysis in acute myocar-dial infarction 422
Cardiac surgery, Continuous low dose inhaled nitric oxide fortreatment of severe pulmonary hypertension after cardiacsurgery in paediatric patients 65
Cardiac tamponade, How do the clinical findings in patients withpericardial effusions influence the success of aspiration? 351
Cardiac transplantationfi adrenoceptor density in the donor heart 540Atheroembolism in an endomyocardial biopsy from a cardiac
transplant recipient after coronary angioplasty 581Cardiomyoplasty, Dynamic cardiomyoplasty for heart failure 1Cardioplegia, Warm blood cardioplegia 206Cardioprotection, New year toast...to the cardioprotective effects
of alcohol 8Cardiopulmonary bypass, Coronary surgery without cardiopul-
monary bypass 203Cardiopulmonary resuscitation, Active decompression improves
the haemodynamic state during cardiopulmonary resuscitation372
Cardiovascular disease, Birth weight, weight at one year, and leftventricular mass in adult life 363
Cardioversion, Value of transoesophageal echocardiography beforeDC cardioversion in patients with atrial fibrillation 306
Cardioverter-defibrillatorBenefits of treatment with implantable cardioverter-defibrillators
in patients with stable ventricular tachycardia without cardiacarrest 158
Implantation of cardioverter-defibrillators at district general hos-pitals 392
Infections after cardioverter-defibrillator implantation 20Catheter ablation, Change in delay of atrioventricular conduction
after radiofrequency catheter ablation for atrioventricular nodalre-entry tachycardia 442
Cellular mechanisms, Cellular mechanisms of cardiac hypertro-phy 496
Central venous cannulation, Safety of thrombolytic treatment inpatients with central venous cannulation 359
Chelation therapy, Reversal ofhaemochromatotic cardiomyopathyin 0 thalassaemia by chelation therapy 486
ChildrenContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65
Nutritional status of children with congenital heart disease 277Twiddler's syndrome in children 190Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544
Cholesterol lowering, Cholesterol lowering does have a role insecondary prevention 4
Clinical trialsACE for whom? Implications for clinical practice of post-infarct
trials 470ACE inhibitors after myocardial infarction 395, 397
Cold intolerance, Vasoconstrictor peptides and cold intolerance inpatients with stable angina pectoris 25
Complications of permanent pacing, Early complications ofpermanent pacemaker implantation 571
Congenital heart defectsCombined atrial and arterial switch procedure for congenitalcorrected transposition with ventricular septal defect 479
Increasing cyanosis early after cavopulmonary connection causedby abnormal systemic venous channels 182
Influence of ethnic origin on the pattern of congenital heartdefects in the first year of life 173
Congenital heart diseaseComparison of three dimensional echocardiographic findings withanatomical specimens of various congenitally malformed hearts566
Nutritional status of children with congenital heart disease 277Congestive heart failure
Effects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237
Peripheral haemodynamic effects of inhibition of prostaglandinsynthesis in congestive heart failure and interactions with capto-pril 434
Responses of plasma concentrations of A type natriuretic peptideand B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heartfailure 584
Constrictive pericarditis, Predictors of constrictive pericarditisafter tuberculous pericarditis 187
Continuous finger blood pressure monitoring, Twenty four hourcontinuous non-invasive finger blood pressure monitoring 290
Convexo-concave, Strut fracture of the Convexo-Concave Bjork-Shiley mitral valve prosthesis 391
Coronary angioplastyAtheroembolism in an endomyocardial biopsy from a cardiac
transplant recipient after coronary angioplasty 581Identification of patients at high risk for adverse coronary eventswhile awaiting routine coronary angioplasty 216
Immediate and long-term clinical outcome of coronary angio-plasty in patients aged 35 years or less 82
Coronary artery bypass surgeryCoronary surgery without cardiopulmonary bypass 203Determinants of the length of stay in intensive care and in hospital
after coronary artery surgery 92Expanding access to coronary artery bypass surgery 129
Coronary artery diseaseCholesterol lowering does have a role in secondary prevention 4Differential autonomic mechanisms underlying early morning anddaytime transient myocardial ischaemia in patients with stablecoronary artery disease 134
Increased monocyte tissue factor expression in coronary disease10
Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242
Coronary artery vasospasm, Positron emission tomography withoxygen-15 of stunned myocardium caused by coronary arteryvasospasm after recovery 69
Coronary atheroembolism, Atheroembolism in an endomyocar-dial biopsy from a cardiac transplant recipient after coronaryangioplasty 581
Coronary care units, National perspective of acute coronary carein the Republic of Ireland 576
Coronary heart diseaseAntioxidant nutrients, atherosclerosis, and coronary heart disease299
National perspective of acute coronary care in the Republic ofIreland 576
Coronary microcirculation, Assessment of coronary microcircu-lation with myocardial contrast echocardiography 490
Corrected transposition, Combined atrial and arterial switch pro-cedure for congenital corrected transposition with ventricularseptal defect 479
Cyanosis, Increasing cyanosis early after cavopulmonary connec-tion caused by abnormal systemic venous channels 182
Cycle length, Effect of exercise on cycle length in atrial flutter 263Cyclic guanosine monophosphate (cGMP), Ergometric exercise
testing and sensitivity of cyclic guanosine 3 ',5 '-monophosphate(cGMP) in diagnosing asymptomatic left ventricular dysfunc-tion 145
Cytokines, Expression of tumour necrosis factor a and accumula-tion of fibronectin in coronary artery restenotic lesions retrievedby atherectomy 534
590
Subject Index
Daytime transient myocardial ischaemia, Differential auto-nomic mechanisms underlying early morning and daytime tran-sient myocardial ischaemia in patients with stable coronaryartery disease 134
Diabetes, Effects of type 1 diabetes mellitus on cardiac function 450Diastolic fimction, Impairment of diastolic function during short-
term anthracycline chemotherapy 61Direct access, Direct access exercise electrocardiography 199District general hospital
Electrophysiology in a district general hospital 76Permanent pacemaker practice at a Scottish district general hospi-
tal between 1987 and 1993 475District general hospitals, Implantation of cardioverter-defibrilla-
tors at district general hospitals 392Diuretics, Please Sir! GPs treat cardiac failure too! 199Doppler echocardiography
Comparison of Doppler echocardiographic methods with heartcatheterisation in assessing aortic valve area in 100 patients withaortic stenosis 293
Left ventricular diastolic function after anthracycline chemother-apy in childhood 340
Left ventricular diastolic function in children measured byDoppler echocardiography 334
Doppler measurement, Doppler reconstruction of left ventricularpressure from functional mitral regurgitation 53
Dual chamber pacing, Early complications of permanent pace-maker implantation 571
Dyspnoea, "Why am I short of breath, doctor?" 393
Early diagnosis, Will serum enzymes and other proteins find a clin-ical application in the early diagnosis of myocardial infarction?102
EchocardiographyComparison of three dimensional echocardiographic findings withanatomical specimens of various congenitally malformed hearts566
Do radionuclide and echocardiographic techniques give a universalcut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466
Economic activity, Are the economically active more deserving?385
ElectrophysiologyElectrophysiology in a district general hospital 76Simultaneous mapping of the tricuspid and mitral valve annuli at
electrophysiological study 377Embolism, Value of transoesophageal echocardiography before DC
cardioversion in patients with atrial fibrillation 306Enalapril withdrawal, Left ventricular volumes, ejection fraction,
and plasma proatrial natriuretic factor (1-98) after withdrawalof enalapril treatment initiated early after myocardial infarction506
Endogenous opioids, Activation and inhibition of the endogenousopioid system in human heart failure 41
Endomyocardial biopsy, Atheroembolism in an endomyocardialbiopsy from a cardiac transplant recipient after coronary angio-plasty 581
Endomyocardial fibrosis, Endomyocardial fibrosis in Egypt 284Endorphins, Increase in plasma ,B endorphins precedes vasodepres-
sor syncope 488Enlarged coronary sinus and superior vena cava, Fetal
echocardiography in detecting anomalous pulmonary venousconnection 355
Enoximone, Quality of life in heart failure treated with enoximone584
Ethnic originInfluence of ethnic origin on the pattern of congenital heart
defects in the first year of life 173Survival after acute myocardial infarction in Asian and white
patients in Birmingham 122Exercise, Ventricular tachycardia and exercise related syncope in
children with structurally normal hearts 544Exercise capacity, Ventilatory responses to exercise in adults after
repair of tetralogy of Fallot 445Exercise testing
Arm-ankle systolic blood pressure difference at rest and after exer-cise in the assessment of aortic coarctation 270
Direct access exercise electrocardiography 199Effect of exercise on cycle length in atrial flutter 263Ergometric exercise testing and sensitivity of cyclic guanosine
3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145
Placebo controlled trial of felodipine in patients with mild to mod-erate heart failure 428
Familial dilated cardiomyopathy, Familial dilated cardiomyopa-thy in the United Kingdom 417
Fast track, Determinants of the length of stay in intensive care andin hospital after coronary artery surgery 92
Felodipine, Placebo controlled trial of felodipine in patients withmild to moderate heart failure 428
Fenestrated total cavopulmonary shunt, Systemic thromboem-bolism leading to myocardial infarction and stroke after fenes-trated total cavopulmonary connection 483
Ferritin, Is increased tissue ferritin a risk factor for atherosclerosisand ischaemic heart disease? 208
Fetal echocardiography, Fetal echocardiography in detectinganomalous pulmonary venous connection 355
Fetal growth, Growth in utero, adult blood pressure, and arterialcompliance 116
Gender, Gender differences in left ventricle geometry and function inpatients undergoing balloon dilatation of the aortic valve for iso-lated aortic stenosis 548
General practitioners, Direct access exercise electrocardiography199
Gingival hyperplasia, Gingival hyperplasia with nifedipine 115Graffito, Guide wire graffito 505
HaemochromatosisHaemochromatosis presenting as congestive cardiac failure 73Reversal of haemochromatotic cardiomyopathy in ,B thalassaemiaby chelation therapy 486
Haemodynamic and renal effects of indomethacin, Peripheralhaemodynamic effects of inhibition of prostaglandin synthesis incongestive heart failure and interactions with captopril 434
Haemodynamic deterioration, Haemodynamic deteriorationafter treatment with adenosine 103
Haemodynamic state during cardiopulmonary resuscitation,Active decompression improves the haemodynamic state duringcardiopulmonary resuscitation 372
Heart failureACE inhibitors after myocardial infarction 395, 397Activation and inhibition of the endogenous opioid system inhuman heart failure 41
Baroreflex sensitivity and cardiovascular mortality in patients withmild to moderate heart failure 517
Combining salicylate and enalapril in patients with coronaryartery disease and heart failure 227
Dynamic cardiomyoplasty for heart failure 1Ergometric exercise testing and sensitivity of cyclic guanosine3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145
Haemochromatosis presenting as congestive cardiac failure 73Placebo controlled trial of felodipine in patients with mild to mod-
erate heart failure 428Please Sir! GPs treat cardiac failure too! 199Quality of life in heart failure treated with enoximone 584
Heart rate variability, Heart rate variability in left ventricularhypertrophy 139
Heparin, Inhibition of superoxide production in human neutrophilsby combinations of heparin and thrombolytic agents 14
Hypertension, Impaired left ventricular filling in hypertensive leftventricular hypertrophy as a marker of the presence of anarrhythmogenic substrate 258
Hypertrophic cardiomyopathy, Pacing for obstructive hyper-trophic cardiomyopathy 107
Hypocalcaemia, Dynamic assessment of the electrocardiographicQT interval during citrate infusion in healthy volunteers 523
Hypoplastic systemic ventricle, Surgery for infants with ahypoplastic systemic ventricle and severe outflow obstruction456
Hysteresis, Dynamic assessment of the electrocardiographic QTinterval during citrate infusion in healthy volunteers 523
Idiopathic dilated cardiomyopathy, Familial dilated cardiomy-opathy in the United Kingdom 417
Implantable defibrillators, Use of the implantable defibrillator 6Incidence, Incidence, clinical characteristics, and short-term prog-
nosis of angina pectoris 193
591
Subject Index
Infancy, Influence of ethnic origin on the pattern of congenitalheart defects in the first year of life 173
Infection, Infections after cardioverter-defibrillator implantation 20Inferior vena cava, Leiomyosarcoma in the right atrium and
occluding the inferior vena cava 236Inflammatory cells, Expression of tumour necrosis factor a and
accumulation of fibronectin in coronary artery restenotic lesionsretrieved by atherectomy 534
Inoue balloon rupture, Inoue balloon rupture during dilatation ofcalcified mitral valves 390
Insulin resistance, Insulin resistance, high prevalence of diabetes,and cardiovascular risk in immigrant Asians 584
Intensive care stay, Determinants of the length of stay in intensivecare and in hospital after coronary artery surgery 92
Interventional closure, Closure of Blalock-Taussig shunts using anew detachable coil device 383
Intracoronary pressureHigh wall shear stress proximal to myocardial bridging and athero-
sclerosis 462Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242
Ischaemia, Prognostic significance of transient myocardialischaemia after first acute myocardial infarction 320
Ischaemic heart disease, Direct access exercise electrocardiogra-phy 199
Left ventricular diastolic function, Suppression of left ventricularearly diastolic filling by long axis asynchrony 151
Left ventricular diastolic function in childrenLeft ventricular diastolic function after anthracycline chemother-apy in childhood 340
Left ventricular diastolic function in children measured byDoppler echocardiography 334
Left ventricular dilatation, Left ventricular volumes, ejectionfraction, and plasma proatrial natriuretic factor (1-98) afterwithdrawal of enalapril treatment initiated early after myocar-dial infarction 506
Left ventricular dysfunctionDetection of left ventricular dysfunction after myocardial infarc-
tion 101Ergometric exercise testing and sensitivity of cyclic guanosine3',5'-monophosphate (cGMP) in diagnosing asymptomatic leftventricular dysfunction 145
Left ventricular ejection fraction, Do radionuclide and echocar-diographic techniques give a universal cut off value for left ven-tricular ejection fraction that can be used to select patients fortreatment with ACE inhibitors after myocardial infarction? 466
Left ventricular enlargement, Birth weight, weight at one year,and left ventricular mass in adult life 363
Left ventricular fimctionDelay between the onset of symptoms of acute myocardial infarc-
tion and seeking medical assistance is influenced by left ventric-ular function at presentation 125
Pathophysiology and time course of silent myocardial ischaemiaduring mental stress 242
Left ventricular hypertrophyHeart rate variability in left ventricular hypertrophy 139Impaired left ventricular filling in hypertensive left ventricularhypertrophy as a marker of the presence of an arrhythmogenicsubstrate 258
Left ventricular mass, Gender differences in left ventricle geometryand function in patients undergoing balloon dilatation of theaortic valve for isolated aortic stenosis 548
Lipid peroxidation products, Transient release of lipid peroxida-tion products as a non-invasive marker of successful reperfusionafter thrombolysis for myocardial infarction 223
Long axis asynchrony, Suppression of left ventricular early dias-tolic filling by long axis asynchrony 151
Magnetic resonance imaging, Aortic distensibility and stiffnessindex measured by magnetic resonance imaging in patients withMarfan's syndrome 265
Mahaim pathways, Radiofrequency catheter ablation of Mahaimtachycardia by targeting Mahaim potentials at the tricuspidannulus 250
Marfan's syndrome, Aortic distensibility and stiffness index mea-sured by magnetic resonance imaging in patients with Marfan'ssyndrome 265
Matrix, Expression of tumour necrosis factor a and accumulation offibronectin in coronary artery restenotic lesions retrieved byatherectomy 534
Medical devices, Medical devices 401Mental stress, Pathophysiology and time course of silent myocar-
dial ischaemia during mental stress 242Mitral regurgitation, Doppler reconstruction of left ventricular
pressure from functional mitral regurgitation 53Mitral stenosis, Percutaneous balloon dilatation of the mitral valve
in critically ill young patients with intractable heart failure 555Mitral valve calcification, Inoue balloon rupture during dilatation
of calcified mitral valves 390Mitral valve hypoplasia, Mitral valve hypoplasia in children with
isolated coarctation of the aorta 199Mitral valve prolapse, Increased dispersion of refractoriness in the
absence of QT prolongation in patients with mitral valve pro-lapse and ventricular arrhythmias 37
Monocytes, Increased monocyte tissue factor expression in coro-nary disease 10
Myocardial bridging, High wall shear stress proximal to myocar-dial bridging and atherosclerosis 462
Myocardial contrast echocardiography, Assessment of coronarymicrocirculation with myocardial contrast echocardiography490
Myocardial infarctionACE for whom? Implications for clinical practice of post-infarct
trials 470ACE inhibitors after myocardial infarction 395, 397Detection of left ventricular dysfunction after myocardial infarc-
tion 101Nitrates in myocardial infarction 310Nocturnal hypoxaemia after myocardial infarction 488Plasma proatrial natriuretic factor (1-98) concentration aftermyocardial infarction 511
QT dispersion and components of the QT interval in ischaemiaand infarction 32
Safety of thrombolytic treatment in patients with central venouscannulation 359
Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223
Will serum enzymes and other proteins find a clinical application inthe early diagnosis of myocardial infarction? 102
Women and myocardial infarction 87Myocardial protection, Role of acadesine in clinical myocardial
protection 304Myocarditis and aortitis, Cardiac involvement in Wegener's gran-
ulomatosis 110
Natriuretic peptides A and B, Responses of plasma concentra-tions ofA type natriuretic peptide and B type natriuretic peptideto alacepril, an angiotensin-converting enzyme inhibitor, inpatients with congestive heart failure 584
Neutrophils, Inhibition of superoxide production in human neu-trophils by combinations of heparin and thrombolytic agents 14
Nifedipine, Gingival hyperplasia with nifedipine 115Nitrates
Nitrates and severe aortic stenosis 586Nitrates in myocardial infarction 310
Nitric oxideContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65
Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177
Nocturnal hypoxaemia, Nocturnal hypoxaemia after myocardialinfarction 488
Non-clinical factors, Are the economically active more deserving?385
Norwood procedure, Surgery for infants with a hypoplastic sys-temic ventricle and severe outflow obstruction 456
Nutritional status, Nutritional status of children with congenitalheart disease 277
Oxygen treatmentEffects of captopril and oxygen on sleep apnoea in patients withmild to moderate congestive cardiac failure 237
Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177
592
Subject Index
Pacemaker failure, Twiddler's syndrome in children 190Pacemaker infection, Antibiotic prophylaxis in permanent pace-
maker implantation 392Pacing
Issues in cardiac pacing 101Pacing for obstructive hypertrophic cardiomyopathy 107Permanent pacing in patients with tricuspid valve replacements169
Permanent pacemaker practice at a Scottish district general hospi-tal between 1987 and 1993 475
Paediatric surgery, Combined atrial and arterial switch procedurefor congenital corrected transposition with ventricular septaldefect 479
Palliation, Surgery for infants with a hypoplastic systemic ventricleand severe outflow obstruction 456
Paradoxical embolism, Near miss paradoxical embolism 103Parasympathetic nervous system, Baroreflex sensitivity and car-
diovascular mortality in patients with mild to moderate heartfailure 517
Patient delay, Delay between the onset of symptoms of acutemyocardial infarction and seeking medical assistance is influ-enced by left ventricular function at presentation 125
Peel index, Detection of left ventricular dysfunction after myocar-dial infarction 101
Percutaneous balloon dilatation, Percutaneous balloon dilatationof the mitral valve in critically ill young patients with intractableheart failure 555
Pericardial effusion, How do the clinical findings in patients withpericardial effusions influence the success of aspiration? 351
Peripheral vascular disease, Peripheral vascular disease 199Polymorphism, Genetic variation in human stromelysin promoter is
associated with progression of coronary atherosclerosis 209Population analysis, Rapid methods for population-scale analysis
for gene polymorphisms 368Positron emission tomography, Positron emission tomography
with oxygen-15 of stunned myocardium caused by coronaryartery vasospasm after recovery 69
Pregnancy, Percutaneous balloon dilatation of the mitral valve incritically ill young patients with intractable heart failure 555
Prevention of reinfarction, Combining salicylate and enalapril inpatients with coronary artery disease and heart failure 227
Primary angioplastyExperience of primary angioplasty in the UK 414Immediate angioplasty 407Immediate angioplasty in the United Kingdom 413Limitations of primary angioplasty in acute myocardial infarction409
Primary angioplasty 405Primary angioplasty in a community hospital in the USA 411Primary angioplasty in acute myocardial infarction 403Primary angioplasty is the most effective treatment for an acutemyocardial infarction 403
Proatrial natriuretic factor (1-98), Plasma proatrial natriureticfactor (1-98) concentration after myocardial infarction 511
PrognosisBaroreflex sensitivity and cardiovascular mortality in patients withmild to moderate heart failure 517
Incidence, clinical characteristics, and short-term prognosis ofangina pectoris 193
Prognostic significance of transient myocardial ischaemia afterfirst acute myocardial infarction 320
Progression of coronary artery disease, Genetic variation inhuman stromelysin promoter is associated with progression ofcoronary atherosclerosis 209
Prophylaxis, Antibiotic prophylaxis in permanent pacemakerimplantation 392
Prospective screening study, Familial dilated cardiomyopathy inthe United Kingdom 417
Prostaglandin, Combining salicylate and enalapril in patients withcoronary artery disease and heart failure 227
ProstaglandinsPeripheral haemodynamic effects of inhibition of prostaglandin
synthesis in congestive heart failure and interactions with capto-pril 434
Responses of the post-term arterial duct to oxygen, prostaglandinE2, and the nitric oxide donor, 3-morpholinosydnonimine, inlambs and their clinical implications 177
Pulmonary hypertensionContinuous low dose inhaled nitric oxide for treatment of severepulmonary hypertension after cardiac surgery in paediatricpatients 65
Endotracheal tolazoline for severe persistent pulmonary hyper-tension of the newbom 99
QT dispersion, Increased dispersion of refractoriness in theabsence of QT prolongation in patients with mitral valve pro-lapse and ventricular arrhythmias 37
QT intervalDynamic assessment of the electrocardiographic QT interval dur-
ing citrate infusion in healthy volunteers 523QT dispersion and components of the QT interval in ischaemiaand infarction 32
Quality of life, Quality of life in heart failure treated with enoxi-mone 584
Radiofrequency ablation, Radiofrequency catheter ablation ofMahaim tachycardia by targeting Mahaim potentials at the tri-cuspid annulus 250
Radionuclide angiographyDo radionuclide and echocardiographic techniques give a universal
cut off value for left ventricular ejection fraction that can beused to select patients for treatment with ACE inhibitors aftermyocardial infarction? 466
Impairment of diastolic function during short-term anthracyclinechemotherapy 61
Rapid genotyping, Rapid methods for population-scale analysis forgene polymorphisms 368
Recurrence, Supravalvar mitral stenosis 164Referral decisions, Are the economically active more deserving?
385Regulations, Medical devices 401Rehabilitation, Report of a working group of the British Cardiac
Society 201Relative wall thickness, Gender differences in left ventricle geom-
etry and function in patients undergoing balloon dilatation ofthe aortic valve for isolated aortic stenosis 548
Renal function, Plasma proatrial natriuretic factor (1-98) concen-tration after myocardial infarction 511
Renin-angiotensin-system, Baroreflex sensitivity and cardiovas-cular mortality in patients with mild to moderate heart failure517
ReperfusionComparison of five cardiac markers in the detection of reperfusion
after thrombolysis in acute myocardial infarction 422Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223
Repolarisation, Ventricular tachycardia and exercise related syn-cope in children with structurally normal hearts 544
Republic ofIreland, National perspective of acute coronary care inthe Republic of Ireland 576
RestenosisEfficacy of a third coronary angioplasty for a second restenosis 327Expression of tumour necrosis factor a and accumulation of
fibronectin in coronary artery restenotic lesions retrieved byatherectomy 534
Potential for antiviral therapy in the treatment of restenosis afterangioplasty 489
Revascularisation, Efficacy of a third coronary angioplasty for asecond restenosis 327
Right atrial leiomyosarcoma, Leiomyosarcoma in the rightatrium and occluding the inferior vena cava 236
Right ventricular dominance, Fetal echocardiography in detect-ing anomalous pulmonary venous connection 355
Risk stratification, Identification of patients at high risk foradverse coronary events while awaiting routine coronary angio-plasty 216
Schistosomiasis, Endomyocardial fibrosis in Egypt 284Secondary prevention, Cholesterol lowering does have a role in
secondary prevention 4Serum enzymes, Will serum enzymes and other proteins find a
clinical application in the early diagnosis of myocardial infarc-tion? 102
Sexism, Women and myocardial infarction 87Single chamber pacing, Early complications of permanent pace-
maker implantation 571Sleep apnoea, Effects of captopril and oxygen on sleep apnoea in
patients with mild to moderate congestive cardiac failure 237Speedwell study, Peripheral vascular disease 199ST depression, Effects of streptokinase in patients presenting
593
Subject Index
within 6 hours of prolonged chest pain with ST segment depres-sion 500
ST segment depression, Detection of left ventricular dysfunctionafter myocardial infarction 101
Stenting, Anticoagulation after intracoronary stent insertion 393Stromelysin, Genetic variation in human stromelysin promoter is
associated with progression of coronary atherosclerosis 209Strut fracture, Strut fracture of the Convexo-Concave Bjork-Shiley
mitral valve prosthesis 391Stunned myocardium, Positron emission tomography with oxy-
gen-15 of stunned myocardium caused by coronary arteryvasospasm after recovery 69
Superoxide production, Inhibition of superoxide production inhuman neutrophils by combinations of heparin and throm-bolytic agents 14
Supravalvar mitral stenosis, Supravalvar mitral stenosis 164Surgery, Increasing cyanosis early after cavopulmonary connection
caused by abnormal systemic venous channels 182Surgical resection, Supravalvar mitral stenosis 164Survival after original infarct, Survival after acute myocardial
infarction in Asian and white patients in Birmingham 122SyncopeHead-up tilt testing 583Increase in plasma ,B endorphins precedes vasodepressor syncope488
Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544
Tachycardia, Radiofrequency catheter ablation of Mahaim tachy-cardia by targeting Mahaim potentials at the tricuspid annulus250
Tetralogy of Fallot, Ventilatory responses to exercise in adults afterrepair of tetralogy of Fallot 445
p thalassaemia, Reversal of haemochromatotic cardiomyopathy in/1 thalassaemia by chelation therapy 486
Three dimensional reconstruction, Comparison of three dimen-sional echocardiographic findings with anatomical specimens ofvarious congenitally malformed hearts 566
Thromboembolism, Systemic thromboembolism leading tomyocardial infarction and stroke after fenestrated total cavopul-monary connection 483
Thrombolysis, Comparison of five cardiac markers in the detectionof reperfusion after thrombolysis in acute myocardial infarction422
Thrombolytic agents, Inhibition of superoxide production inhuman neutrophils by combinations of heparin and throm-bolytic agents 14
Thrombolytic treatmentEffects of streptokinase in patients presenting within 6 hours ofprolonged chest pain with ST segment depression 500
Is thrombolytic therapy in acute inferior myocardial infarctionreally better than conventional treatment? 108
Transient release of lipid peroxidation products as a non-invasivemarker of successful reperfusion after thrombolysis for myocar-dial infarction 223
National perspective of acute coronary care in the Republic ofIreland 576
Safety of thrombolytic treatment in patients with central venouscannulation 359
Thrombotic markers, Increased markers of thrombogenesis inchronic atrial fibrillation 527
Tilt testing, Head-up tilt testing 583Tissue factor, Increased monocyte tissue factor expression in coro-
nary disease 10Tolazoline, Endotracheal tolazoline for severe persistent pulmonary
hypertension of the newbom 99
Training, Training in cardiology 302Transcatheter occlusion
Closure of Blalock-Taussig shunts using a new detachable coildevice 383
Transcatheter occlusion of cardiac defects 585Transoesophageal echocardiography
Cardiac involvement in Wegener's granulomatosis 110Value of transoesophageal echocardiography before DC car-
dioversion in patients with atrial fibrillation 306Tricuspid annulus, Radiofrequency catheter ablation of Mahaim
tachycardia by targeting Mahaim potentials at the tricuspidannulus 250
Tricuspid valve replacement, Permanent pacing in patients withtricuspid valve replacements 169
Tuberculous pericarditis, Predictors of constrictive pericarditisafter tuberculous pericarditis 187
Twiddler's syndrome, Twiddler's syndrome in children 190Twins, Effects of type 1 diabetes mellitus on cardiac function 450
Ultrasonics, High wall shear stress proximal to myocardial bridgingand atherosclerosis 462
Unstable angina, Effects of streptokinase in patients presentingwithin 6 hours of prolonged chest pain with ST segment depres-sion 500
USA, Use of the implantable defibrillator 6
Vasoconstrictor peptides, Vasoconstrictor peptides and coldintolerance in patients with stable angina pectoris 25
Venesection, Haemochromatosis presenting as congestive cardiacfailure 73
Ventilatory response, Ventilatory responses to exercise in adultsafter repair of tetralogy of Fallot 445
Ventricular arrhythmia, Increased dispersion of refractoriness inthe absence of QT prolongation in patients with mitral valveprolapse and ventricular arrhythmias 37
Ventricular fibrillation, QT dispersion and components of theQT interval in ischaemia and infarction 32
Ventricular function, Effects of type 1 diabetes mellitus on cardiacfunction 450
Ventricular late potentials, Impaired left ventricular filling inhypertensive left ventricular hypertrophy as a marker of thepresence of an arrhythmogenic substrate 258
Ventricular septal defect, Morphological, haemodynamic, andclinical variables as predictors for management of isolated ven-tricular septal defect 49
Ventricular tachycardiaBenefits of treatment with implantable cardioverter-defibrillators
in patients with stable ventricular tachycardia without cardiacarrest 158
Impaired left ventricular filling in hypertensive left ventricularhypertrophy as a marker of the presence of an arrhythmogenicsubstrate 258
Ventricular tachycardia and exercise related syncope in childrenwith structurally normal hearts 544
Wall stress, High wall shear stress proximal to myocardial bridgingand atherosclerosis 462
Warfarin, Increased markers of thrombogenesis in chronic atrialfibrillation 527
Warm blood, Warm blood cardioplegia 206Wegener's granulomatosis, Cardiac involvement in Wegener's
granulomatosis 110Weight at one year, Birth weight, weight at one year, and left ven-
tricular mass in adult life 363
Young patients, Immediate and long-term clinical outcome ofcoronary angioplasty in patients aged 35 years or less 82
594